
APT Medical Inc.
- Jurisdiction
China - ISIN
CNE100004C45 (688617.SS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. Read full profile
Stock price
Fundamentals
- Net revenue
€274.46M - Gross margin
72.8% - EBIT
€102.04M - EBIT margin
37.2% - Net income
€91.03M - Net margin
33.2%
Statement period: - (published )
Dividends
- Last dividend amount
-
CN¥1.21 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
40.2%